Guided Therapeutics (GTHP) Other Non-Current Assets (2014 - 2025)

Guided Therapeutics has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $17000.0 for Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $17000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $17000.0 (changed 0.0% YoY), and the FY2025 annual result was $17000.0, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $17000.0 for Q4 2025 at Guided Therapeutics, roughly flat from $17000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $18000.0 in Q1 2021 to a low of $17000.0 in Q2 2021.
• The 5-year median for Other Non-Current Assets is $17000.0 (2021), against an average of $17050.0.
• Peak annual rise in Other Non-Current Assets reached 5.88% in 2021, while the deepest fall reached 96.55% in 2021.
• Guided Therapeutics' Other Non-Current Assets stood at $17000.0 in 2021, then changed by 0.0% to $17000.0 in 2022, then changed by 0.0% to $17000.0 in 2023, then changed by 0.0% to $17000.0 in 2024, then changed by 0.0% to $17000.0 in 2025.
• The last three Other Non-Current Assets figures came in at $17000.0 (Q4 2025), $17000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.